EDAP - צמיחת הכנסות ב-12 חודשים נגררים EDAP TMS S.A.

The French medtech manufacturer EDAP TMS S.A. (EDAP) is expanding its direct presence in the US by integrating local distributors. Annual revenue growth over a rolling period demonstrates that the figure stands at 0.00. Insurance payouts and stable demand for urology ensure business resilience. The leadership of EDAP TMS S.A. (EDAP) is based on Focal One, the gold standard for minimally invasive tumor ablation without surgical incisions.
EDAP TMS SA (EDAP) - פילוחי מדדים ודוחות פיננסיים

The business resilience of EDAP TMS S.A. is based on recurring revenues from services and consumables for Focal One systems. By analyzing the trailing twelve-month (TTM) sales growth rate, an investor can see the scaling dynamics of this model. This metric compares revenue over the last 12 months with the same period last year, neutralizing seasonality and the base effect. A steady upward trend confirms market expansion, allowing for an objective adjustment of the discounted value of assets.